Cough Suppressant Drugs Market Will Generate New Growth Opportunities in Upcoming Year

Cough Suppressant Drugs Market - Snapshot

Three types of medicines can ease a cough caused by a cold or bronchitis: cough suppressants, expectorants, and ointments you apply to your skin called topicals. Suppressants do their job by blocking your cough reflex. Dextromethorphan is the most common ingredient for this. You’ll see it listed as on the bottle or package. This type of medication isn’t used to treat a cough with mucus. And it can’t relieve pain like the medicine codeine -- you'll need a doctor’s prescription for cough suppressant drugs with that in it.

This combination medication is used to relieve coughs caused by the common cold, bronchitis, and other breathing illnesses. Guaifenesin belongs to a class of drugs known as expectorants. It works by thinning and loosening mucus in the airways, clearing congestion, and making breathing easier. Dextromethorphan belongs to a class of drugs known as cough suppressants drugs. It acts on a part of the brain (cough center) to reduce the urge to cough. The doctor may tell you not to treat a cough from a cold unless it keeps you up at night or gets in the way of your daily life. Coughing up mucus helps keep your lungs clear. This is especially true if you smoke or have asthma or emphysema. Dextromethorphan can affect drugs that treat depression. Also, some combination cold and cough medicines contain decongestants, which can raise your blood pressure. So skip them if your BP is high or if you have heart disease.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=68183

Antitussive therapies have gained wide clinical acceptance for treating dry cough and chronic cough, including in cases where the exact cause is hard to identify. These therapies have gained preference in health care due to the fact that they can reduce coughing regardless of the etiology. The drug pipeline in cough-suppressant therapies has grown on the back of the steady demand from the target population in general clinical settings. Drugmakers in the cough suppressants drugs market have tried new mucolytic agents, particularly for managing cough in patients with bronchitis. Of note, range of products containing these agents have been used for addressing the problem caused due to mucociliary factors. Ongoing efforts to prove the effectiveness of the existing class of protussive agents have created new avenues for pharmaceutical companies in the cough suppressants drugs market. The strides have been stridently bolstered by the adoption of evidence-based guidelines especially that which relate to chronic cough. A growing population seeking outpatient care for chronic bronchitis in hospitals has also spurred the sales of products over the past decades.

Industry efforts to developing drugs that demonstrate consistent action on mucociliary factors have set the tone of innovation in cough suppressants drugs market. In recent years, research on inhaled anticholinergic agents in bronchitis has intensified, which has greatly shaped the product development lifecycle of many drugmakers in the market.

Request for Analysis of COVID19 Impact on Cough Suppressant Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=68183

Cough Suppressant Drugs Market Introduction

Cough is a reflex action that clears the throat of mucus or any sort of foreign irritants. Coughing is the most common symptom of a number of medical conditions. According to a study published in the Journal of the Association of Physicians of India, cough is the sixth most common reason for hospital outpatient department visit. Factors that increase the risk of dry cough include exposure to pollutants/environmental irritants, residence close to heavy traffic leading to respiratory problems, cigarette smoking, asthma, chronic obstructive airway disease, use of angiotensin converting enzyme, acute & chronic infections, airway diseases, parenchymal disease, cardiovascular, and gastrointestinal.

Based on type, cough can be divided into acute cough and chronic cough. Cough suppressants are also known as antitussives. Cough suppressants inhibit cough coordinating region in the brain stem. High prevalence of cough is projected to increase demand for cough suppressant drugs during the forecast period, which in turn is anticipated to drive the global cough suppressant drugs market.

Pre Book Cough Suppressant Drugs Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=68183<ype=S

Cough Suppressant Drugs Market – Competitive Landscape

The global cough suppressant drugs market is highly fragmented with several domestic players holding key market share in respective region. The low cost of manufacturing, easy availability of these products, large volume business for cough suppressant drugs and easy entry for new players into cough suppressant drugs market. All these factors have attracted large number of domestic manufacturers into this field. Major players operating in the global cough suppressant drugs market focus on business expansion and are engaged in mergers and collaborations.

Perrigo Company plc

Perrigo Company plc is an Ireland-based company that generates 70% of its revenue from the U.S. and has significant presence in the global cough suppressant drugs market. The Company is a leading provider of over-the-counter health and wellness solutions.

Pfizer, Inc

Pfizer, Inc. is another multinational company with strong presence in the cough suppressant drugs market in North America. Pfizer Inc. is a global pharmaceutical company that develops, manufactures, and markets prescription medicines in 11 therapeutic segments, including cardiovascular, oncology, neuroscience, pain, and infectious diseases. It operates through two business units: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).

Read More Information:

https://www.transparencymarketresearch.com/cough-suppressant-drugs-market.html

GlaxoSmithKline

GlaxoSmithKline is a global pharmaceutical company actively involved in research, development and manufacturing innovative pharmaceutical medicines, vaccines and consumer healthcare products. In 2018, GlaxoSmithKline invested around 4.60 Mn USD for research and development of pipeline products.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals worldwide. The company delivers high-quality and patient-centric health care solutions across the globe. It has a wide generic product portfolio with more than 35,000 products in almost every therapeutic area.The company primarily operates through two business segments : Generic medicines and specialty medicines.Teva Pharmaceutical Industries Ltd. markets its gout therapeutic drug under its generic medicines business segment

Other players operating in the global cough suppressant drugs market include Tris Pharma, Inc., Aytu BioScience, Inc., Mayne Pharma Group Limited, and Acella Pharmaceuticals, LLC.

Browse more Market Reports:

Ophthalmic Knives Market:

https://www.transparencymarketresearch.com/ophthalmic-knives-market.html

Canes and Crutches Market:

https://www.transparencymarketresearch.com/canes-crutches-market.html

Sirolimus Market:

https://www.transparencymarketresearch.com/sirolimus-market.html

Abbott:

Abbott is another key player operating in the global valvular heart disease market with vast product portfolio. Abbott has established its presence in the global market through acquisition of St. Jude Medical in 2017. In January 2019, Abbott acquired Cephea Valve Technologies, Inc. This acquisition enabled the company to strengthen its position in valvular heart disease market.

Medtronic:

Medtronic offers its valvular heart disease products under its Cardiac & Vascular Group (CVG). In 2018, around 38% of the company’s revenue was contributed by its CVG business segment. Medtronic has one of the industry leading portfolio of Cough Suppressant Drugs products.

Browse more Market Reports:

Medical Foods Market:

https://www.transparencymarketresearch.com/medical-foods-market.html

Assistive Technologies Demand for Visually Impaired Market:

https://www.transparencymarketresearch.com/assistive-technologies-visually-impaired-market.html

Veterinary Ventilators Market:

https://www.transparencymarketresearch.com/veterinary-ventilators-market.html

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.